TrialClinical pharmacology in drug development2026
Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy Adults.
Sunil Soitawala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.